SCHEMBL5029973

SCHEMBL5029973

Cc1ccc(O[Si](Cl)(Cl)Cl)c(C)c1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21522238 0.80 MAPT (0.46)
SCHEMBL8733344 0.73 NCEH1 (0.33) NCEH1
SCHEMBL18854378 0.72 NCEH1 (0.35) NCEH1
SCHEMBL5031031 0.71 ACHE (0.41)
SCHEMBL141853 0.70 ACHE (0.44)
SCHEMBL13489641 0.70 NCEH1 (0.32) NCEH1
Hydrochloric Acid SCHEMBL9739649 0.69 ACHE (0.42)
SCHEMBL6722517 0.69 NCEH1 (0.33) NCEH1
SCHEMBL29071347 0.69 POLB (0.33) NCEH1
SCHEMBL11376078 0.69 NCEH1 (0.33) NCEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed